AI-generated summary
This review examines recent research on the causes of lymphedema, which the authors describe as fundamentally an immunologic process involving inflammation, fibroadipose deposition, impaired lymphangiogenesis, and dysfunctional lymphatic pumping. The authors report that these findings have led to emerging medical and surgical therapies that may potentially change current care, which has largely relied on compression, and they aim to give an overview of these therapies. The abstract does not report any study results for specific treatments.
- Who or what was studied
- Patients who undergo treatment for a solid tumor, affected by lymphedema
- Limits stated in the abstract
- The abstract describes a review and does not report outcome data or efficacy for the emerging therapies it mentions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on annualreviews.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.